• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Intermountain Ventures Invest in Omada Health to Expand Relationship

by Fred Pennic 10/10/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Intermountain Ventures Invest in Omada Health to Expand Relationship

– Intermountain Ventures, the strategic investment arm of Intermountain Healthcare has invested in digital care leader Omada Health.

– The announcement expands the relationship with Intermountain Healthcare that began five years ago in 2016 and comes off the heels of Omada’s recent $73M funding round.

– The Omada Program became a covered benefit for Intermountain employees and their adult dependents in 2019.

Today, Omada Health announced a milestone investment from Intermountain Ventures, the strategic investment arm of Intermountain Healthcare. This investment comes on the heels of their recent $73 million funding round and expands a relationship with Intermountain Healthcare that began five years ago, signaling the continued industry shift towards deeply integrated, value-based care. The Omada Program became a covered benefit for Intermountain employees and their adult dependents in 2019.

Impact of Investment

As Omada works to reconceptualize Omada as a provider of  “21st century healthcare”, there’s a huge opportunity when it comes to digital health solutions integrating with value-based health systems. This deepening relationship with Intermountain Healthcare further solidifies Omada’s position to provide a roadmap for large healthcare organizations seeking to integrate digital health solutions.

Digital Therapeutics for Chronic Disease

Omada works with more than 600 employers and health plans across all 50 states, delivering an integrated experience that adapts to participants’ health needs, and personalizes their journeys to create the best health outcomes. Omada’s dedicated coaches guide each individual throughout the program, achieving unparalleled engagement and sustainable behavior change. Omada’s proprietary coaching platform enables them to deliver personalized interventions at scale. The company proved the model for digital care as the nation’s largest CDC-recognized provider of the National Diabetes Prevention Program, and has now launched programs over the last twelve months for diabetes self-management, as well as anxiety and depression, to holistically address individuals’ health needs.

Peer-Reviewed Studies

Omada has published 11 peer-reviewed studies and is currently running the largest-ever randomized controlled trial of digital diabetes prevention. The company’s approach is proven to deliver lasting clinical outcomes, as well as significant medical cost savings, across diverse populations. Omada’s program drives unprecedented levels of meaningful engagement by participants, directly leading to sustained improvements in health.

Why It Matters

“Ten years from now, the most engaging and utilized healthcare provider in the U.S. will be digital. Omada is poised to be that provider, as we inspire and engage the more than 100 million patients who need additional care and support between physician visits,” said Omada Health CEO and co-founder Sean Duffy. “Today’s announcement — and the incredible roster of investors participating in this round of fundraising — will deepen our collaboration with health plans, employers, and health systems, and accelerate the development of our truly personalized program that helps participants build patterns for lifelong health.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: behavior, Depression, diabetes, digital health, Digital Therapeutics, Health IT Venture Capital, Health Systems, Intermountain Healthcare, model, Omada Health, Value-Based Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |